Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 4/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | CASP7 | P55210 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.32 |
| ▸ | CDK1 | P06493 | 1/20 | 0.32 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.32 |
| ▸ | GSK3A | P49840 | 1/20 | 0.32 |
| ▸ | GSK3B | P49841 | 1/20 | 0.32 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.32 |
| ▸ | TOP1 | P11387 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7717019 | 0.89 | STAT3 (0.38) | TERT | |
| SCHEMBL6099752 | 0.89 | TERT (0.32) | TERT | |
| SCHEMBL7157187 | 0.89 | AMY1A (0.32) | TERTCCNB2CDK1CCNB1GSK3A | |
| SCHEMBL7161173 | 0.88 | STAT3 (0.38) | TERT | |
| SCHEMBL6101964 | 0.88 | TERT (0.31) | TERT | |
| SCHEMBL6101513 | 0.88 | TERT (0.31) | TERT | |
| SCHEMBL6101961 | 0.86 | TERT (0.30) | TERT | |
| SCHEMBL6101510 | 0.85 | — | — | |
| SCHEMBL7158629 | 0.85 | TOP1 (0.36) | TERTTOP1 | |
| SCHEMBL7155911 | 0.84 | TOP1 (0.36) | TERTTOP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6429310-B2 | PHOTONIC OR ELECTRONIC ENERGY CONDUCTING | NARA INSTITUTE OF SCIENCE AND TECHNOLOGY (JP) | 2002-08-06 | — | — | US | disclosed |
| US-20010018515-A1 | Poly(porphyrin) having imidazolyl porphyrin metal complex as unit | NARA INSTITUTE OF SCIENCE AND TECHNOLOGY (JP) | 2001-08-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010018515-A1 | Poly(porphyrin) having imidazolyl porphyrin metal complex as unit | AP1M1, AP3M1, AP2M1 | TERT 1111/4885KDM4E 3399/4885CASP1 2402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.